JPH041738B2 - - Google Patents

Info

Publication number
JPH041738B2
JPH041738B2 JP59028424A JP2842484A JPH041738B2 JP H041738 B2 JPH041738 B2 JP H041738B2 JP 59028424 A JP59028424 A JP 59028424A JP 2842484 A JP2842484 A JP 2842484A JP H041738 B2 JPH041738 B2 JP H041738B2
Authority
JP
Japan
Prior art keywords
acid
groups
group
methyl group
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59028424A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59163356A (ja
Inventor
Satsutojingaa Geruharuto
Heruman Manfuretsuto
Furitsutosuki Edogaa
Baierushauzen Ute
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goedecke GmbH
Original Assignee
Goedecke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke GmbH filed Critical Goedecke GmbH
Publication of JPS59163356A publication Critical patent/JPS59163356A/ja
Publication of JPH041738B2 publication Critical patent/JPH041738B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
JP59028424A 1983-02-19 1984-02-17 Ｎ−フエニルベンズアミド誘導体ならびにその製造法および応用 Granted JPS59163356A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3305755.9 1983-02-19
DE19833305755 DE3305755A1 (de) 1983-02-19 1983-02-19 N-phenyl-benzamid-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkranungen des immunsystems

Publications (2)

Publication Number Publication Date
JPS59163356A JPS59163356A (ja) 1984-09-14
JPH041738B2 true JPH041738B2 (enExample) 1992-01-14

Family

ID=6191259

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59028424A Granted JPS59163356A (ja) 1983-02-19 1984-02-17 Ｎ−フエニルベンズアミド誘導体ならびにその製造法および応用

Country Status (16)

Country Link
US (3) US4857662A (enExample)
EP (1) EP0116967B1 (enExample)
JP (1) JPS59163356A (enExample)
AT (1) ATE17715T1 (enExample)
AU (1) AU565185B2 (enExample)
CA (1) CA1244050A (enExample)
DD (1) DD216452A5 (enExample)
DE (2) DE3305755A1 (enExample)
DK (2) DK166383C (enExample)
ES (1) ES8501368A1 (enExample)
GR (1) GR79506B (enExample)
HU (1) HU195474B (enExample)
IE (1) IE56587B1 (enExample)
SU (1) SU1333234A3 (enExample)
YU (1) YU43563B (enExample)
ZA (1) ZA841187B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤
ATE80034T1 (de) * 1985-03-01 1992-09-15 Goedecke Ag Verwendung von 2-(aminophenyl)-benzimidazolderivaten fuer die herstellung von arzneimitteln zur bekaempfung maligner und nicht maligner proliferativer sowie autoimmuner erkrankungen und zur immunsuppression bei transplantationen.
DE3625359A1 (de) * 1986-07-26 1988-02-04 Goedecke Ag N-(2'-aminophenyl)-benzamid-derivat, verfahren zu dessen herstellung und dessen verwendung bei der bekaempfung neoplastischer erkrankungen
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
DE3705117A1 (de) * 1987-02-18 1988-09-01 Goedecke Ag Verwendung von benzothiazepin-derivaten, insbesondere diltiazem bei der protektion von lymphozyten
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
CA2367262A1 (en) 1999-03-22 2000-09-28 Craig R. Travis Treatment of immune diseases
US20020137802A1 (en) * 2000-09-28 2002-09-26 Travis Craig R. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
WO2002026728A2 (en) * 2000-09-28 2002-04-04 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
US6878714B2 (en) * 2001-01-12 2005-04-12 Amgen Inc. Substituted alkylamine derivatives and methods of use
US7102009B2 (en) 2001-01-12 2006-09-05 Amgen Inc. Substituted amine derivatives and methods of use
US6995162B2 (en) 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
US20030134836A1 (en) * 2001-01-12 2003-07-17 Amgen Inc. Substituted arylamine derivatives and methods of use
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
US20030186942A1 (en) * 2002-01-16 2003-10-02 Crooks Peter A. Compounds of use in the treatment of epilepsy, seizure, and electroconvulsive disorders
GB0202873D0 (en) * 2002-02-07 2002-03-27 Novartis Ag Organic compounds
US20030232101A1 (en) * 2002-03-18 2003-12-18 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
US7307088B2 (en) * 2002-07-09 2007-12-11 Amgen Inc. Substituted anthranilic amide derivatives and methods of use
MX2007007038A (es) * 2004-12-09 2008-03-07 Insys Therapeutics Inc Formulacion de dronabinol en temperatura ambiente.
US8247556B2 (en) * 2005-10-21 2012-08-21 Amgen Inc. Method for preparing 6-substituted-7-aza-indoles
AU2007281918A1 (en) * 2006-08-04 2008-02-14 Insys Therapeutics Inc. Aqueous dronabinol formulations
CA2698752A1 (en) * 2007-08-06 2009-02-12 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
WO2009076234A2 (en) * 2007-12-07 2009-06-18 University Of Maryland, Baltimore Synthesis methods of histone deacetylase inhibitors (hdacis)
KR20220163384A (ko) 2020-03-04 2022-12-09 플레오파마, 엘.엘.씨. 칸나비스 사용 장애를 치료하고 칸나비노이드 금단을 완화하기 위한 방법 및 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2022579A (en) * 1929-02-14 1935-11-26 Turski Joseph Felix 2,3-hydroxy-naphthoic acid arylamide
GB1123457A (en) * 1966-07-11 1968-08-14 Warner Lambert Pharmaceutical 2-amino-4'-(diethylamino)-2'-methyl benzanilide and preparation thereof
US3488388A (en) * 1967-03-29 1970-01-06 Universal Oil Prod Co N-substituted aminobenzenecarboxamides
US3926922A (en) * 1974-03-14 1975-12-16 Polaroid Corp Polyurethane elastomers prepared from diamine curing agents
FR2279822A1 (fr) * 1974-07-24 1976-02-20 Ugine Kuhlmann Nouveaux colorants disazoiques hydrosolubles et nouvelles matieres premieres utilisables pour leur preparation
JPS5671075A (en) * 1979-11-12 1981-06-13 Sumitomo Chem Co Ltd Novel imidazole derivative
JPS5721320A (en) * 1980-07-11 1982-02-04 Chugai Pharmaceut Co Ltd Blood sugar level depressing agent

Also Published As

Publication number Publication date
YU28784A (en) 1986-08-31
GR79506B (enExample) 1984-10-30
DK57492A (da) 1992-05-01
ZA841187B (en) 1984-09-26
ES529811A0 (es) 1984-11-16
DD216452A5 (de) 1984-12-12
HU195474B (en) 1988-05-30
IE56587B1 (en) 1991-10-09
JPS59163356A (ja) 1984-09-14
ES8501368A1 (es) 1984-11-16
CA1244050A (en) 1988-11-01
YU43563B (en) 1989-08-31
DE3305755C2 (enExample) 1989-08-03
EP0116967A1 (de) 1984-08-29
EP0116967B1 (de) 1986-01-29
IE840122L (en) 1984-08-19
DE3460026D1 (en) 1986-03-13
DK166383C (da) 1993-09-27
DE3305755A1 (de) 1984-08-23
ATE17715T1 (de) 1986-02-15
DK76784D0 (da) 1984-02-17
AU565185B2 (en) 1987-09-10
US4816485A (en) 1989-03-28
DK76784A (da) 1984-08-20
DK57492D0 (da) 1992-05-01
US4857662A (en) 1989-08-15
DK166383B (da) 1993-05-10
SU1333234A3 (ru) 1987-08-23
US4933368A (en) 1990-06-12
DK168268B1 (da) 1994-03-07
AU2440184A (en) 1984-08-23

Similar Documents

Publication Publication Date Title
JPH041738B2 (enExample)
JP6937090B2 (ja) 免疫調節剤としての１，２，４−オキサジアゾールおよびチアジアゾール化合物
JP3133345B2 (ja) Ｈｉｖに対して活性な連結環状ポリアミン
JP2888453B2 (ja) ニューモシスティス−カリニ肺炎の治療用または予防用の製薬組成物
ES2702495T3 (es) Formulaciones de derivados de decitabina
KR20010022878A (ko) 전립선암 치료를 위한 티로신 키나아제 억제제 및 화학적 거세법의 조합
JPS62249923A (ja) パ−キンソン病、うつ病、ナルコレプシ−および脳器官精神症候群の抑制用薬剤およびその製造方法
JPH11506421A (ja) 腸感染に対する薬物の調製のためのフマギロールおよびその誘導体の使用
JP5693970B2 (ja) ベンゾフェナントリジン構造を有する抗腫瘍薬およびそれらを含有する製剤
JP2511159B2 (ja) 免疫欠損状態の治療のための医薬製剤
PT98731B (pt) Processo para a preparacao de um sal de codeina de um acido carboxilico substituido
EP0497001A2 (en) Oxidized-type glutathione alkyl ester
JPH02326B2 (enExample)
NL8105635A (nl) Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
EP0215200A2 (en) Use of sulfanilamido quinoxalines in the treatment of neoplastic diseases
EP0232697B1 (en) Pharmaceutical compositions containing acth fragments for the therapy of shock conditions and of respiratory and cardiocirculatory insufficiencies
CN101395143A (zh) 用于治疗疟疾或aids的氮杂杂环化合物
WO1986006960A2 (en) Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
JP2002363076A (ja) フマギロール誘導体を用いる腫瘍の治療方法
AU619027B2 (en) Method for suppressing immune responses by administering imexon
WO1995020388A1 (en) Anti-hiv drugs
JP2834507B2 (ja) 芳香族誘導体を活性成分とする疾患治療剤
JPH0616561A (ja) 抗レトロウイルス剤
JPS60158114A (ja) 転移抑制性制がん剤
JPH03190822A (ja) 抗炎症活性を有する新規な製薬組成物

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term